These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 20126594

  • 1. Congenital short QT syndrome.
    Crotti L, Taravelli E, Girardengo G, Schwartz PJ.
    Indian Pacing Electrophysiol J; 2010 Feb 01; 10(2):86-95. PubMed ID: 20126594
    [Abstract] [Full Text] [Related]

  • 2. Short QT syndrome: a review.
    Patel U, Pavri BB.
    Cardiol Rev; 2009 Feb 01; 17(6):300-3. PubMed ID: 19829181
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Short QT syndrome. Genotype-phenotype correlations.
    Borggrefe M, Wolpert C, Antzelevitch C, Veltmann C, Giustetto C, Gaita F, Schimpf R.
    J Electrocardiol; 2005 Oct 01; 38(4 Suppl):75-80. PubMed ID: 16226079
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Familial short QT syndrome].
    Lupoqlazoff JM, Denjoy I.
    Rev Prat; 2007 Jan 31; 57(2):121-5. PubMed ID: 17432514
    [Abstract] [Full Text] [Related]

  • 9. Clinical and molecular genetics of the short QT syndrome.
    Schimpf R, Borggrefe M, Wolpert C.
    Curr Opin Cardiol; 2008 May 31; 23(3):192-8. PubMed ID: 18382206
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome.
    Harrell DT, Ashihara T, Ishikawa T, Tominaga I, Mazzanti A, Takahashi K, Oginosawa Y, Abe H, Maemura K, Sumitomo N, Uno K, Takano M, Priori SG, Makita N.
    Int J Cardiol; 2015 May 31; 190():393-402. PubMed ID: 25974115
    [Abstract] [Full Text] [Related]

  • 12. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun 31; 18(6):658-64. PubMed ID: 17521304
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical characteristics and treatment of short QT syndrome.
    Wolpert C, Schimpf R, Veltmann C, Giustetto C, Gaita F, Borggrefe M.
    Expert Rev Cardiovasc Ther; 2005 Jul 31; 3(4):611-7. PubMed ID: 16076272
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
    Luo C, Wang K, Zhang H.
    PLoS One; 2017 Jul 31; 12(6):e0179515. PubMed ID: 28632743
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome.
    Patel C, Antzelevitch C.
    Heart Rhythm; 2008 Apr 31; 5(4):585-90. PubMed ID: 18362027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.